Clinical Trials Browser

Completed × Observational × Taxes × Clear all

NCT04133155 2020-03-13

Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

Gastrointestinal

Pancreatic Neoplasms